Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Depreciation & Amortization (CF): 2020-2023

Historic Depreciation & Amortization (CF) for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2023 value amounting to $335,000.

  • ADC Therapeutics' Depreciation & Amortization (CF) rose 104.27% to $335,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.2 million, marking a year-over-year increase of 11.98%. This contributed to the annual value of $1.3 million for FY2024, which is 12.38% up from last year.
  • ADC Therapeutics' Depreciation & Amortization (CF) amounted to $335,000 in Q4 2023, which was up 6.01% from $316,000 recorded in Q3 2023.
  • ADC Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $420,000 for Q2 2021, and its period low was -$274,000 during Q4 2021.
  • For the 3-year period, ADC Therapeutics' Depreciation & Amortization (CF) averaged around $263,917, with its median value being $303,000 (2022).
  • Data for ADC Therapeutics' Depreciation & Amortization (CF) shows a peak YoY increase of 159.85% (in 2022) and a maximum YoY decrease of 28.81% (in 2022) over the last 5 years.
  • Over the past 4 years, ADC Therapeutics' Depreciation & Amortization (CF) (Quarterly) stood at $292,000 in 2020, then spiked by 35.27% to -$274,000 in 2021, then soared by 159.85% to $164,000 in 2022, then surged by 104.27% to $335,000 in 2023.
  • Its last three reported values are $335,000 in Q4 2023, $316,000 for Q3 2023, and $273,000 during Q2 2023.